Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Junctional Bradycardia with Cardiorenal Syndrome

View through CrossRef
Junctional bradycardia occurs when electrical activity at the SA node is disrupted, or there is a conduction block originating from the SA node, or its automaticity is less than the AV node or HIS bundle. A 46-year-old female was referred because of shortness of breath and swollen limbs. The patient has a long history of diabetes and hypertension. She was diagnosed with acute pulmonary edema, junctional bradycardia, stage 4 CKD, CHF, hypoalbuminemia, anemia, and T2DM. The patient was admitted to the ICCU for 7 days before being discharged. Cardiorenal syndrome can induce sinus node dysfunction or AV node dysfunction, leading to junctional bradycardia. Subsequently, the junctional bradycardia exacerbates concomitant heart failure and renal failure.
Title: Junctional Bradycardia with Cardiorenal Syndrome
Description:
Junctional bradycardia occurs when electrical activity at the SA node is disrupted, or there is a conduction block originating from the SA node, or its automaticity is less than the AV node or HIS bundle.
A 46-year-old female was referred because of shortness of breath and swollen limbs.
The patient has a long history of diabetes and hypertension.
She was diagnosed with acute pulmonary edema, junctional bradycardia, stage 4 CKD, CHF, hypoalbuminemia, anemia, and T2DM.
The patient was admitted to the ICCU for 7 days before being discharged.
Cardiorenal syndrome can induce sinus node dysfunction or AV node dysfunction, leading to junctional bradycardia.
Subsequently, the junctional bradycardia exacerbates concomitant heart failure and renal failure.

Related Results

Incidence and risk factors of bradycardia in pediatric patients undergoing intranasal dexmedetomidine sedation
Incidence and risk factors of bradycardia in pediatric patients undergoing intranasal dexmedetomidine sedation
BackgroundDexmedetomidine is widely used for non‐invasive pediatric procedural sedation. However, the hemodynamic effects of intravenous dexmedetomidine are a concern. There has be...
MO667: Creating a New Cardiorenal Unit: 3-Year Study Results
MO667: Creating a New Cardiorenal Unit: 3-Year Study Results
Abstract BACKGROUND AND AIMS Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart...
Roles for SGLT2 Inhibitors in Cardiorenal Disease
Roles for SGLT2 Inhibitors in Cardiorenal Disease
<b><i>Introduction:</i></b> Cardiovascular (CV) disease and chronic kidney disease (CKD) share common risk factors, including type 2 diabetes mellitus (T2D...
Incidence of intra‐operative bradycardiaComparison of atracurium and vecuronium in gynaecological surgery
Incidence of intra‐operative bradycardiaComparison of atracurium and vecuronium in gynaecological surgery
Intra‐operative bradycardia is one of the most common cardiac arrhythmias observed in clinical anaesthetic practice and can lead to a potentially dangerous outcome. In a randomised...
Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome
Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome
Background: The interaction between the heart and kidneys involves complex mechanisms, leading to a clinical condition known as cardiorenal syndrome (CRS), where dysfunction in one...
Abstract 17124: Severe Bradycardia in Critically Ill Patients With COVID-19
Abstract 17124: Severe Bradycardia in Critically Ill Patients With COVID-19
Cardiac manifestations of severe Covid19 infection are still poorly understood. From January to May 2020, 113 consecutive patients were admitted in intensive care units for severe ...

Back to Top